The National Community Pharmacists Association has summarized the federal reforms to pharmacy benefit manager practices signed into law via the recent funding bill signed by President Trump. The measures are contained in a bill to fund the Department of Health and Human Services. The new law requires the Centers for Medicare & Medicaid Services to define and enforce “reasonable and relevant” Medicare Part D contract terms, and gives enforcement authority; promotes transparency by allowing CMS to track payment trends to pharmacies and pharmacy inclusion in PBM networks, including a new designation of essential retail pharmacies; and prohibits PBM compensation in Medicare Part D from being tied to the manufacturer’s list price of a drug in an effort to reduce drug prices and save money for taxpayers.